Skip to main content
OpenTrials
Completed

NCT Number: NCT03589001

24 Month Follow-up of Patients With Osgood Schlatter (OSD)

Osgood Schlatter is a common knee condition, affecting approximately 10% of adolescents. OSD is thought to be a growth related pain conditon, and thus resolve after maturation. Despite this, there a lack of prospective data investigating whether this is in fact the case.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–14 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Unit for General Practice in Aalborg

Aalborg, 9220 Ø, Denmark

About this study

This is a prospective cohort study of 51 adolescents (aged 10-14 at baseline) with Osgood schlatter. Participants are followed for two years.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 10-14 years of age
  • Pain at tibial tuberosity during two or more of the following activities: Sitting with a bent knee, squatting, running, jumping or stair ambulation
  • Pain during palpation of tibial tuberosity
  • Knee pain for 6 weeks or more

Exclusion criteria

  • Other knee conditions that may manifest as anterior knee pain (Patellofemoral pain, iliotibial band syndrome, sinding-larson-johanson disease).
  • Previous surgery
  • Pain from the hip or back that interferes with activities of daily living.
  • Habitual patella luxations
  • Clinical suspicion of meniscal lesion

Treatment and study plan

Activity modification

Other

Activity modification, exercises and gradual return to sport

Primary outcomes

  1. Current knee pain

    Time frame: 24 months

    Participants self-report if they still have knee pain

Secondary outcomes

  1. Pain intensity

    Time frame: 24 months

    Worst pain in the previous week measured on a visual analogue scale (VAS) from 'no pain' to 'worst imaginable pain'

  2. Pain frequency

    Time frame: 24 months

    Frequency of knee pain divided into (almost daily, several times per week, weekly, monthly, rarely, never)

  3. Duration of being pain-free

    Time frame: 24 months

    Those who no longer have knee pain will be asked how long since their knee pain resoved

  4. Medical attention

    Time frame: 24 months

    Participants will be asked to report if they sought medical attention outside of the intervention

  5. Use of pain killers

    Time frame: 24months

    Participants will be asked if they use painkillers to manage their knee pain (y/n). If yes, they will be asked how often.

  6. knee injury and osteoarthritis outcomes score (KOOS) sport and activity subscale

    Time frame: 24 months

    knee injury and osteoarthritis outcomes score (KOOS) subscale sport and activity. Minimum 0 points, maximum 100points, with 100 points being the best possible score.

  7. Sports participation

    Time frame: 24 months

    Participants will report if they participate in sport. If yes how often and how much/week. They will also report if they have reduced sports participation due to knee pain.

  8. Health Related quality of life

    Time frame: 24 months

    Health related quality of life assessed by EQ 5D 3L Y (EuroQol, 5 dimensions, 3 levels for youth). Minimum 0, maximum 1, with higher values indicating higher quality of life.

  9. Sleep

    Time frame: 24 months

    Participants will be asked if they find it hard to sleep because of their knee pain (not at all, some nights, most nights).

Sponsors and collaborators

Lead sponsor

Aalborg University

Other

Registry information

Official study title

A Prospective Investigation of Osgood Schlatter With 24 Month Follow-up

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Jul 17, 2018
Registry last updated
Jul 2, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.